An increased EMAT is associated with lower cardiac function, reflecting possible adverse prognosis.
The analysis indicates linkage between higher EMAT and decline in LVEF metrics.
Results stem from a community cohort demonstrating correlation of electromechanical timing with clinical outcomes.
Identifying EMAT's role in heart function may inform patient prognostic evaluations.
Abstract
In a community cohort, an increased EMAT was associated with a lower LVEF and adverse prognosis but had poor discriminatory capacity for the former and was not independent of NT-proBNP for the latter.